Drug Alert: CDSCO Flags 19 formulations As Not Of Standard Quality Medical Dialogues Team24 April 2021 11:45 AM ISTNew Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) flagged 19 medicine...
Monitor supply of drugs under COVID Treatment Protocol including Remdesivir, Toclizomab: MHA to States, UTs Medical Dialogues Team23 April 2021 7:34 PM ISTNew Delhi: The Ministry of Home Affairs (MHA) has issued a notice to all Union Territories (UTs) and States urging them to monitor the supply of...
Health Ministry nod to Tamsulosin HCL, Deflazacort FDC for treating Asthma Medical Dialogues Team22 April 2021 3:48 PM ISTNew Delhi: Through a recent gazette notification, the Union Health Ministry has approved the Fixed-Dose Combination (FDC) of Tamsulosin HCI and...
Submit 28 days trial results of Hepatitis C drug for Covid-19: CDSCO panel to Zydus Cadila Medical Dialogues Team21 April 2021 11:12 AM ISTNew Delhi: In response to the drug major Zydus Cadila's proposal for marketing authorisation of the Hepatitis C drug, Pegylated Interferon Alpha-2b...
CDSCO Allows Import Of Drugs With Residual Shelf Life Less Than 60 Percent Till October 31, 2021 Medical Dialogues Team20 April 2021 12:06 PM ISTNew Delhi: To ensure drug availability in sufficient quantity in the domestic market, the apex drug regulator, Central Drugs Standard Control...
CDSCO extends Licence validity for 8 medical devices by additional 6 months Medical Dialogues Team19 April 2021 3:56 PM ISTNew Delhi: In order to ensure continued access to medical devices notified as drugs while the new regulatory order under the Medical Device Rules...
Prices of Remdesivir slashed, now as cheap as Rs 899, says NPPA Farhat Nasim18 April 2021 11:03 AM ISTNew Delhi: Through a recent office memorandum, National Pharmaceutical Pricing Authority (NPPA) has announced a reduction in the price of seven brands...
NPPA directs Cipla, Sun Pharma, others to reduce Remdesivir MRP Medical Dialogues Team17 April 2021 4:13 PM ISTNew Delhi: With the demands of Covid-19 drug Remdesivir shooting up, the National Pharmaceutical Pricing Authority (NPPA) has directed drugmakers...
Macleods Pharma gets CDSCO panel okay for BE study of COVID drug Favipiravir Powder for Oral Suspension Medical Dialogues Team16 April 2021 4:48 PM ISTNew Delhi: Pharmaceutical major Macleods Pharma has got a go-ahead from the Subject Expert Committee (SEC) of the Central Drugs Standard Control...
Setback to JnJ: Health agencies ask to halt use of Covid-19 vaccine over blood clot warning Medical Dialogues Team15 April 2021 4:57 PM ISTNew Delhi: In a major setback to Johnson and Johnson, the US Centers for Disease Control and Prevention and the US Food and Drug Administration...
Dr Reddys Baddi unit gets Drug Controller nod to produce Remdesivir for domestic use Medical Dialogues Team14 April 2021 4:36 PM ISTBaddi: Drug major Dr Reddy's Laboratories' has recently secured permission from the Drug Controller to develop the antiviral Remdesivir, which is a...
Make remdesivir available like paracetamol: HC reprimands Gujarat Govt over COVID drug shortage Medical Dialogues Team13 April 2021 4:17 PM ISTThe state government's claim that only seven firms manufacture Remdesivir in the country and that 1.75 lakh vials are made every day was rejected by...
